Claritev (CTEV) traded flat 0 % during a 24 hours period ending at 05:03 PM Central Europe on Monday 26th. One Claritev stock can currently be bought for about USD 23.57 on popular exchanges. Current supply of Claritev stocks is 16.9 mn. Claritev has a current market capitalization of USD 398.3 mn and approximately USD 16.2 mn worth of Claritev was traded on exchanges in the last 24 hours. Since last month end, Claritev has traded 0.6 % up. Simple moving average of last 200 days is at USD 25.87. The highest price of past 52 weeks was recorded at USD 73.68 on 11/07/2025. 52 weeks low was at USD 11.5 on 05/18/2026.
Here is how related stocks have performed in the past 24 hours:
Neurogene (NGNE) traded down -3.01 % and now trades at USD 23.64. Current market capitalisation for Neurogene is USD 471.3 mn.
Arvinas (ARVN) traded down -5.44 % and now trades at USD 7.31. Current market capitalisation for Arvinas is USD 477.3 mn. Current price/earnings ratio for Arvinas is 54.38.
Barnes & Noble Education (BNED) traded down -2.72 % and now trades at USD 13.52. Barnes & Noble Education has a market capitalisation of USD 470.4 mn. Current price/earnings ratio for Barnes & Noble Education is 21.01.
Concrete Pumping (BBCP) traded flat 0 % and now trades at USD 9.46. Current market capitalisation for Concrete Pumping is USD 472.7 mn. Current price/earnings ratio for Concrete Pumping is 56.71.
Monopar Therapeutics (MNPR) traded down -2.66 % and now trades at USD 70.08. Monopar Therapeutics has a market capitalisation of USD 474.2 mn.
About Claritev
The MultiPlan Corporation is a health care software solution provider, headquartered in New York. Their mission is to offer cost management solutions with payment integrity, healthcare networks, and data analytics services, catering to customers in the State of New York. They are listed on the New York Stock Exchange. Their website is www.multiplan.us .
